Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.
Saved in:
| Title: | Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. |
|---|---|
| Authors: | Garey KW; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Jo J; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Gonzales-Luna AJ; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas., Lapin B; Cleveland Clinic, Cleveland, Ohio., Deshpande A; Cleveland Clinic, Cleveland, Ohio., Wang E; Seres Therapeutics, Inc, Cambridge, Massachusetts., Hasson B; Seres Therapeutics, Inc, Cambridge, Massachusetts., Pham SV; AESARA, Inc, Chapel Hill, North Carolina., Huang SP; AESARA, Inc, Chapel Hill, North Carolina., Reese PR; Apex, North Carolina., Wu H; CR Medicon, Piscataway, New Jersey., Hohmann E; Massachusetts General Hospital, Boston., Feuerstadt P; Yale University School of Medicine, New Haven, Connecticut.; PACT-Gastroenterology Center, Hamden, Connecticut., Oneto C; Vanguard Gastroenterology, New York, New York., Berenson CS; University at Buffalo, VA Western New York Healthcare System, Buffalo., Lee C; University of British Columbia, British Columbia, Canada.; Island Medical Program, University of Victoria, British Columbia, Canada., McGovern B; Seres Therapeutics, Inc, Cambridge, Massachusetts., vonMoltke L; Seres Therapeutics, Inc, Cambridge, Massachusetts. |
| Source: | JAMA network open [JAMA Netw Open] 2023 Jan 03; Vol. 6 (1), pp. e2253570. Date of Electronic Publication: 2023 Jan 03. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36716031 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Garey+KW%22">Garey KW</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Jo+J%22">Jo J</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gonzales-Luna+AJ%22">Gonzales-Luna AJ</searchLink>; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Lapin+B%22">Lapin B</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Deshpande+A%22">Deshpande A</searchLink>; Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hasson+B%22">Hasson B</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pham+SV%22">Pham SV</searchLink>; AESARA, Inc, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Huang+SP%22">Huang SP</searchLink>; AESARA, Inc, Chapel Hill, North Carolina.<br /><searchLink fieldCode="AU" term="%22Reese+PR%22">Reese PR</searchLink>; Apex, North Carolina.<br /><searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; CR Medicon, Piscataway, New Jersey.<br /><searchLink fieldCode="AU" term="%22Hohmann+E%22">Hohmann E</searchLink>; Massachusetts General Hospital, Boston.<br /><searchLink fieldCode="AU" term="%22Feuerstadt+P%22">Feuerstadt P</searchLink>; Yale University School of Medicine, New Haven, Connecticut.; PACT-Gastroenterology Center, Hamden, Connecticut.<br /><searchLink fieldCode="AU" term="%22Oneto+C%22">Oneto C</searchLink>; Vanguard Gastroenterology, New York, New York.<br /><searchLink fieldCode="AU" term="%22Berenson+CS%22">Berenson CS</searchLink>; University at Buffalo, VA Western New York Healthcare System, Buffalo.<br /><searchLink fieldCode="AU" term="%22Lee+C%22">Lee C</searchLink>; University of British Columbia, British Columbia, Canada.; Island Medical Program, University of Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22McGovern+B%22">McGovern B</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22vonMoltke+L%22">vonMoltke L</searchLink>; Seres Therapeutics, Inc, Cambridge, Massachusetts. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101729235%22">JAMA network open</searchLink> [JAMA Netw Open] 2023 Jan 03; Vol. 6 (1), pp. e2253570. <i>Date of Electronic Publication: </i>2023 Jan 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101729235 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2574-3805 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225743805%22">25743805 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Netw Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36716031 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamanetworkopen.2022.53570 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2253570 Titles: – TitleFull: Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Garey KW – PersonEntity: Name: NameFull: Jo J – PersonEntity: Name: NameFull: Gonzales-Luna AJ – PersonEntity: Name: NameFull: Lapin B – PersonEntity: Name: NameFull: Deshpande A – PersonEntity: Name: NameFull: Wang E – PersonEntity: Name: NameFull: Hasson B – PersonEntity: Name: NameFull: Pham SV – PersonEntity: Name: NameFull: Huang SP – PersonEntity: Name: NameFull: Reese PR – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Hohmann E – PersonEntity: Name: NameFull: Feuerstadt P – PersonEntity: Name: NameFull: Oneto C – PersonEntity: Name: NameFull: Berenson CS – PersonEntity: Name: NameFull: Lee C – PersonEntity: Name: NameFull: McGovern B – PersonEntity: Name: NameFull: vonMoltke L IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 01 Text: 2023 Jan 03 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2574-3805 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: JAMA network open Type: main |
| ResultId | 1 |